Unconventional Cancer Treatments
Index of Topics

To go to a passage, click on the appropriate page link and, when the chapter opens, use your browser's
"find" command to locate the key word. This index can be quickly navigated by clicking on the letters.
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
Accepted Dental Therapeutics, 187
Advances in Experimental and Clinical Chemotherapy, 94
Adverse effects, 234-235
Antineoplastons, 93, 95
biologically guided chemotherapy, 118, 119
cellular treatments, 98
Chinese medicine, 69
coffee enemas, 51
defined, 15
dietary treatments, 42, 47, 60, 63-64
dimethyl sulfoxide, 99-100
Gerson treatment, 47
herbal treatments, 69, 79, 84, 87
Immuno-Augmentative Therapy, 131-132, 136, 138-140, 143, 233-235
information on, general 15, 17, 26
Iscador, 84, 87 laetrile, 103, 107, 201
Livingston-Wheeler regimen, 110
macrobiotics, 60, 63-64
oxygen treatments, 114
selenium, 118, 119
vitamin C, 121, 122, 123, 126
see also Toxicity
Agua del Sol, 222-223
AIDS, 136-137, 139-140, 209
Aihara, Herman, 60 A
Alliance for Alternative Medicine, 173
Allopathic medicine, 216
Alternatives: New Developments in the War Against Breast Cancer, 157
AMA Drug Evaluations, 187
American Cancer Society
dietary regimens, 41, 42, 44, 64, 208
hydrazine sulfate, 100
Immuno-Augmentative Therapy, 131, 135
information dissemination, general, 11, 153, 157, 164-166, 169
insurance eligibility, 5, 186
psychosocial support, 30
Revici, Emanuel 115, 118
statistics, 11
Unproven Methods List, 5, 15, 44, 60, 100, 112, 115, 164-166, 168, 191
American Council on Science and Health, 156-157
American Medical Association, 5, 12, 215
Gerson treatment, 4344
Hoxsey treatment, 81
Immuno-Augmentative Therapy, 140, 141, 168
information dissemination, general 11, 153, 157,164, 166-168, 169, 187; see also Journal of the American Medical Association
insurance reimbursement and, 187, 189, 191
macrobiotics, 60
American Quack: Association, 169, 171
American Society for Clinical Oncology, 140, 141, 164, 168-169, 233
Animal research, 226-227
Antineoplastons, 95
biologically guided chemotherapy, 118
Essiac, 73
Immuno-Augmentative Therapy (IAT) 133-135
laetrile, 103-104
ozone infusion, 114
vitamin C, 121
Annals of the New York Academy of Sciences, 135
Anthroposophy, 14, 81, 82-84, 85
Antineoplastons, 14, 91-97, 157, 162, 182, 183, 206-207, 210, 219, 323
adverse effects, 93, 95
clinical trials, 93-95
effectiveness, 93-97
Food and Drug Administration, 92, 219
metastasis, 96
remission, 94-95, 96-97
Ascorbic acid, see Vitamin C
Assessment, see Evaluation
Association of Community Cancer Centers, 166, 191
Attitudes
as cancer cause/cure, 29, 31-34
patients, 3, 24-25, 49, 50, 61, 140, 147, 154-155, 192-193
Autogenous vaccine, Livingston-Wheeler regimen, 14, 41, 107-111, 183, 211-212
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
B
Bacillus Calmette-Guerin, 168
Bahamas, 15, 131, 136, 137, 139, 143, 145, 146, 147, 149, 162, 179, 234
Bailar, John, 10, 141
Barberry, 78
Basic Macrobiotics, 60
Beadle, George, 134
Beard Howard, 104
Beard, John, 102
Behavioral approaches, see Psychological and Behavioral approaches
Benjamin, Harold, 30
Bergsagel, Daniel, 96
Best case approach, 23, 25, 97, 142, 231-233
Beta carotene, 63, 113
Biological approaches, see Immuno-Augmentative Therapy; Immunological system; Pharmacologic and biologic approaches
Biologically guided chemotherapy (Revici), 14, 115-120, 169, 173-174, 202, 203, 220-221
Biological response modifiers, 12
Blackstein, Martin, 96
Bladder and bladder cancer, 93, 94-95, 99, 185
Block, Keith, 13-14, 44
Blood products, Immuno-Augmentative Therapy, 4, 8, 15, 19, 22, 131-149, 153, 158, 162, 168, 173, 182, 192, 211, 230-231, 234-235
Blue Cross/Blue Shield, 187-188, 190, 195
Bone cancer, 93, 96, 122-123, 127
Boyle v. Revici, 223
Breast cancer, 11, 33, 36-37, 92, 93, 95, 103-104, 106, 108, 111, 135, 157
Brenner, Seymour, 120
Buckthorn, 78
Burdock, 78
Burk, Dean, 104
Burton, Lawrence, 15, 131-149 (passim), 158
Burzynski, Stanislaw, 14, 91-97, 157, 163, 182, 183, 194, 206-207, 210, 219
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
C
CA-A Cancer Journal for Clinicians, 166
Cachexia, 92, 100
Caisse, Rene, 14, 71-72, 73-74
California Institute of Technology, 133, 134
Cameron, Ewan, 21, 120-127 (passim)
Canada, 14, 71, 74-75, 179, 181
Cancer and Vitamin C, 122
Cancer: A New Breakthrough, 109
Cancer as a Turning Point, 33
Cancer Control Journal, 169
Cancer Control Society, 113, 169-170
Cancer Forum, 171
Cancer Information Service, 25, 153, 161-163
Nieper, Hans, 112
Cancer Manual, 166
The Cancer Prevention Diet, 60, 61, 62, 64
The Cancer Survivors and How They Did It, 138, 157
A Cancer Therapy: Results of Fifty Cases, 45, 47, 48
Cancer? Think Curable: The Gerson Therapy, 48
Cancer Victors Journal, 170
Cascara, 78
Case histories
Antineoplastons, 96-97
biologically guided chemotherapy, 117
dietary treatments, 20-21, 45, 48, 55-58
Gerson treatment, 45, 48
herbal treatments, 71, 74, 80-81
Immuno-Augmentative Therapy, 142-143
Kelley regimen, 55-58
laetrile, 104-106
macrobiotics, 65-66
Pau D'Arco, 87
vitamin C, 122
Cassileth, Barrie, 18, 139, 140-141, 153, 185, 218, 230-231
Cellular treatment, 97-98
Center for Alternative Cancer Research, 172
Centers for Disease Control, 131, 137, 139
Certification, see Licenses and permits
Cervical cancer, 96
Chaparral, 70-71
Charting the Journey: The Cancer Survivors' Almanac of Resources, 157
Chelation therapy, 189, 219
Chemotherapy, 11-12, 202
biologically guided (Revici), 14, 115-120, 169, 173-174, 202, 203, 220
breast cancer, 36
colon/rectal cancer, 10, 11
conventional, 8-9
fraud, 194
herbal sources, 69
Children, 18, 200
Chiropractic treatment, 187
Chlebowski, Rowan, 101
The Choice, 172
City of Carter Lake v. Aetna, 192
Civilian Health and Medical Program of the Uniformed Services, 186
Civil suits, see Litigation
Clement, John, 132, 141, 143
Clinical Oncology, 166
Clinical trials, 12, 21-23, 162, 227-230, 234, 235
adjunctive treatments, 229
Antineoplastons, 93-95
biologically guided chemotherapy, 119-120
eumetabolics, 113
Gerson treatment, 49
herbal treatments, 69, 80-81
hydrazine sulfate, 15, 21, 100-101
Immuno-Augmentative Therapy (IAT) 22, 142-149
insurance eligibility and, 177-178
Iscador, 86
laetrile, 21-22, 104-105, 106-107
Livingston-Wheeler regimen, 110
radiotherapy, 9
vitamin, C, 21, 122-125, 126
Coalition for Alternative Medicine, 172-173
Coalition for Alternatives in Nutrition and Healthcare, 169, 171
Coffee enemas, 45-46, 47, 51, 49, 52, 55
Cole, Donald, 222
Colon cancer, 10, 11, 36, 56, 84, 93, 96, 106, 123,125, 144, 148
Committee for Freedom of Choice in Medicine, 172, 209
Commonweal Cancer Help Program, 31
Comprehensive Crime Control Act, 206
The Conquest of Cancer, 109
Consumer protection, 156
v. "freedom of choice," 7, 199, 200-203, 209
litigation, 6
see also Cancer Information Service; Fraud; Food and Drug Administration
Contract law, 186, 187-188, 189, 191, 192, 193-195
Conventional treatment, 8-10, 155
controversies, 10-11
evaluation, 226-228
unconventional treatments and, 178
see also Diet an nutrition: adjunctive uses
Costs, 3, 18-19, 177
clinic charges, factors, 178-185
dietary treatments, 178, 180,
information on, 178-179, 181, 182, 185
biologic and pharmacologic approaches, 179-180, 181, 184
see also Insurance; Medicare
Counseling
psychosocial, 29-31
spiritual 12
Court cases, see Litigation
Crime and criminals, 6, 16, 18, 201, 205-206, 207, 222-223
fines, 206, 207, 209, 211, 221
malpractice, 202, 215, 218, 222, 223
racketeering, 194, 210
unlicensed practitioners, 16, 26, 199, 215, 217, 222
see also Fraud
Criminal Fines Enforcement Act, 206
Current Procedural Terminology, 194
Customs controls, see Import controls

3-26

69-87
151-156
197-210 
239-243
Top
GH I
 OP QR
29-37
 91-126
 159-172
 213-221
244-245
 A B C
JKL
S T UV
 41-66 
 129-147
175-193
225-235
245-249 
 D E F
M N
WYZ
D
Dallis v. Aetna, 192-193
Data bases, 78, 226
National Cancer Institute, 153, 161, 163
Decisionmaking, by patients, 10, 30, 154-155, 157-158
Defender Magazine, 79
Department of Health and Human Services, 221
see also Medicare; specific administrative subunits
DeVita, Vincent, 100
Diagnosis
biologically guided chemotherapy, 117
costs, 178, 181
Kelley regimen 53
Diet and Health, 121
Diet and nutrition, 12, 13-14, 41-66, 155, 164, 208
adjunctive uses, 14, 42-43, 44, 101, 110, 111, 122, 229
adverse effects, 42, 47, 60, 63-64
American Cancer Society, 41, 42, 44, 64, 208
carbohydrates, 113
case histories, 20-21, 45, 48, 55-58
cost of treatment and, 178, 180, 184
eumetabolics and, 111, 112-113
evaluation of, 48-50, 55-58, 64-66, 229
Gerson Teatment, 13, 22, 41, 43-50, 114, 162-163, 192, 215
hydrazine sulfate, 101
Kelley regimen, 13, 20-21, 42, 51, 51-58
macrobiotics, 12, 14, 41-42, 58-66, 162
litigation, 192
Livingston-Wheeler regimen, 110
quality of life, 43, 49, 50
sodium, 43, 46, 113
wheatgrass regimen, 41, 42
see also specific vitamins
Diet, Nutrition, and Cancer, 208
Dimethyl sulfoxide, 14, 99-100, 222
Disciplinary measures, practitioners, 7, 212, 215, 217-222
Kelley regimen, 54
malpractice, 202, 215, 218, 222, 223
vitamins, 192
Donsbach, Kurt, 99-100, 114
Dr. Donsbach Tells You What You Always Wanted to Know About DMSO, 99-100
Drugs
see also Chemotherapy; Pharmacologic and biologic approaches
Drugs Under Experimental and Clinical Research, 94
Dulbecco, Renato, 134
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
 
E
Eastern philosophy, 58-59, 60-61
Economic factors, see Costs; Financial arrangements; Insurance
Educational attainment, patients, 154
Educational programs, 166, 216
Effectiveness, 3, 20, 23-24, 25, 226, 230-233
Antineoplastons, 93-97
best case, 23, 25, 51, 97, 142, 231-233
biologically guided chemotherapy, 116-117, 118
Federal role, 6, 199,203,205; see also National Cancer Institute, Food and Drug Administration
Gerson treatment, 47-50
herbs, 72-73, 77-81, 84-86
Hoxsey treatment, 77-81
hydrazine sulfate, 100-102
imagery and visualization 35-38
Immuno-Augmentative Therapy (IAT) 132, 148 147 168, 230-231
information on, 25
insurance eligibility and, 177-178, 185-186, 189-190 192
Iscador, 84-86, 87
Kelley regimen, 56
laetrile, 103-107, 201-202
Livingston-Wheeler regimen, 110-111
macrobiotics, 64
meditation, 34
pharmacologic and biologic approaches, 83
psychological/behavioral approaches, 33
vaccines, 110-111
vitamin, C, 120, 121-122, 122-127
wheatgrass regimen, 41
see also Clinical trials
Employee Retirement Income Security Act, 193
Enemas, 189
coffee, 45-46, 47, 49, 51, 52, 55
oxygen, 15, 47, 114
Essiac, 14, 71-75, 183
Etoposide, 69
Eumetabolic treatments, 14, 111-113, 172
Evaluation, 19-24, 225-235
Alliance for Alternative Medicine, 173
American Medical Association, 168, 187
Antineoplastons, 95-97, 232
best case, 23, 25, 97, 142, 231-233
biologically guided chemotherapy, 118-120
dietary treatments, 48-50, 55-58, 6~66, 229
Gerson treatment, 48-50, 232
herbal treatments, 74, 80-81, 86
history, 4-5
Hoxsey treatment, 80-81
hypnosis, 36-37
Immuno-Augmentative (IAT), 132, 140-147, 168, 230-231, 234-235
insurance eligibility and, 177-178, 185-186, 189-191
Kelley regimen, 55-58
laetrile, 21-22, 103-107, 201-202, 232
Livingston-Wheeler regimen, 110-111
macrobiotics, 64-66
multifaceted treatments, 22
pharmacological and biological approaches, general, 228-229
psychobehavioral approaches, 14, 10, 20, 36-37
radiotherapy, 9
vitamin, C, 22, 122-127, 232-233
see also Clinical trials; Effectiveness; Pre-clinical testing; Quality control
Exceptional Cancer Patients, 31, 36, 231
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
F
False Representation Statute, 208
Federal Government, 203-210, 211-212, 217-218, 221, 234-235
Essiac, 74-75
evaluation standards, 5
evaluation support, 24
Federal Trade Commission, 7, 162, 164, 167, 207-208
funding, 5, 24-26
Hoxsey treatment, 81
Immuno-Augmentative Therapy, 131
information dissemination, 24-25, 161-164
Medicaid, 186, 210
Medicare, 16, 19, 117, 185, 186-187, 190, 195, 210,221-222, 223
State governments, relations with, 6, 210, 211-212
technical assistance, 24
see also Food end Drug Administration; Laws, specific Federal; National Cancer Institute
Federal Trade Commission, 7, 162, 164, 167, 207-208
Federal Trade Commission Act, 207-208
Federation of State Medical Boards, 218-219
Fever, 84
Filary v. General American Life Ins. Co., 193
Financial arrangement, 177-195
fraud, billing, 194
see also Costs; Insurance
Fines, 206, 207, 209, 211, 221
Fishbein, Morris, 5, 75
Fitzgerald, Benedict, 81
Florida, 131, 140, 161-162
Food, see Diet and nutrition
Food and Drug Administration, 6, 7, 19, 22, 203-207, 209, 210, 219, 226, 229-230, 233, 234
Antineoplastons, 92, 219
dimethyl sulfoxide, 99
herbal treatments, 69, 75
hydrazine sulfate, 100
Immuno-Augmentative Therapy, 131, 142, 143, 145, 147, 148, 192
information dissemination, general, 154, 162, 163-164, 166, 167
insurance reimbursement, 186-192 (passim), 195
laetrile, 21, 22, 192, 201-202
Nieper, Hans, 112, 173
ozone infusion, 114
Food and Drugs Act of 1906, 6
Food, Drug, and Cosmetic Act, 5-6, 7, 112, 131, 167, 199-200, 201-202, 203-207, 210, 211, 219
Foreign countries, 7
insurance, 8, 49, 187, 188, 189
see also specific countries and regions
Foundation for Advancement in Cancer Therapies, 169, 171
Foundation for Alternative Medicine, 173
Fraud, 161, 202, 207-209, 210, 221, 222-223
American Medical Association activities, 5, 167
information on, 16, 26, 164, 169
insurance, 19, 186, 189-190, 194, 223
psychic healers, 13
Free v. Travelers, 192, 193
Fritz, Norman, 48
Funding
evaluations, 25-26
research, 5, 24-25
 
 
 
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
G
General Accounting Office, 10-11
Gerber, Michael, 219-220
Gerson treatment, 13, 22, 41, 43-50, 114, 162-163, 192, 215
American Medical Association, 43-44
case histories, 45, 48
evaluation, 48-50, 232
metastasis, 49
State actions, 43, 215
Gold, Joseph, 100
Gonzalez, Nicholas, 13, 20, 21, 54-56, 58
Grossarth-Maticek, Ronald, 36
Halstead, Bruce, 222-223
Has Dr. Max Gerson a True Cancer Cure, 7, 48
Health Care Financing Administration, 186, 187, 190
Healthcare Rights Advocate, 171
Health Consciousncss, 171
Health food stores, 16, 17, 156-157
Health Freedom News, 170
Henne v. Mutual of Omaha, 192
Hepatitis, 136-137, 139
Herbal treatments, 12, 14, 70-87, 69-87
adverse effects, 69, 79, 84, 87
Agua del Sol 222-223
Anthroposophy, 14, 81, 82-84, 85
case histories, 71, 74, 80-81
chaparral 70-71
clinical trials, 69, 80-81
costs of, 179, 182
Essiac, 14, 71-75, 183
evaluation, 74, 80-81, 86
Food and Drug Administration 69, 75
Hoxsey treatment, 14, 73, 75-81, 157, 167, 182, 219
mistletoe, 13, 14, 81-86, 87
National Cancer Institute, 69, 74, 78, 80-81
Pau D'Arco, 14, 86-87
In re Hofbauer, 202
Homemaker's magazine, 72
Homeopathy, 189, 217
Hormonal treatment, 9, 110
Hoxsey: Quacks Who Cure Cancer?, 75, 157, 167
Hoxsey treatment, 14, 73, 75-81, 157, 167, 181, 219
American Medical Association, 81
litigation, 75, 80, 81
Hydrazine sulfate, 15, 21, 100-102, 163
Hydrogen peroxide, 114, 209
Hyperthermia, 168
financial costs of, 180, 185
Hypnosis, 33, 36-37
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
I
Imagery and visualization, 13, 33, 35-36
Immuno-Augmentative Therapy (IAT), 4, 8, 15, 19, 22, 131-149, 153, 158, 162, 168, 173, 182, 183, 192, 211, 230-231, 234-235
adverse effects, 131-132, 136, 138-140, 143, 233-235
American Cancer Society, 131, 135
American Medical Association, 140, 141,
168 case histories, 142-143
clinical trials, 22, 142-149
evaluation, 132, 140-147, 168, 230-231, 234-235
Food and Drug Administration, 131, 142, 143, 145, 147, 148, 192
metastasis, 143, 148 National Cancer Institute, 131, 139, 140, 141, 142, 145, 148-149, 234
patents, 137-140
preclinical testing, 133-136, 137, 139
quality of life, 144, 149
remission, 134, 135, 140
State actions, 131, 136, 140, 211
Imperial Cancer Research Fund, 119
Import controls, 163, 209
Immuno-Augmentative Therapy, 131
Nieper, Hans, 112, 173
Indian rhubarb, 73
Infection
Gerson treatment effects, 47
Immuno-Augmentative Therapy, 136-137, 139-140, 234-235
Livingston-Wheeler regimen, 14, 41, 107-111, 183, 211-212
Information and information dissemination 4, 15-16, 17, 19, 24-26
adverse effects, general, 15, 17, 26
American Cancer Society, general 11, 153, 157, 164-166, 169
American Medical Association, general 157, 164, 166-168, 169, 187; see also Journal of thc American Medical Association
bibliographies, 168
biologically guided chemotherapy, 116
cost of treatment, 178-179, 181, 182, 185
Federal, 24-25, 161-164; see also Cancer Information Service
Food and Drug Administration, general 154, 162, 163-164, 166, 167
on fraud, 16, 26, 164, 169
macrobiotics, 62
National Cancer Institute, 153, 161-163; see also Cancer Information Service
Nieper, Hans, 112
patient sources, 17, 19, 153, 155-157, 178, 182, 185
private sector, 164-174
see also Data bases; Mass media; Telephone services;
Inpatient treatment, costs, 178-181
Insurance, 18-19, 177-178, 185-195, 213, 215
American Cancer Society, eligibility and, 5, 186
American Medical Association, eligibility and 187, 189, 191
Blue Cross/Blue Shield, 187-188, 190, 195
commercial 189-190, 191-192
Food and Drug Administration, 186-192 (passim), 195
foreign countries, 8, 49, 187, 188, 189
fraud 19, 186, 189-190, 194, 223
litigation, 186, 191-194, 195
Medicaid 186, 210
Medicare, 16, 19, 117, 185, 186-187, 190, 195, 210, 221-222, 223
National Cancer Institute, 186, 191
quality of life, eligibility and, 177, 185-186, 192
State actions, 188-189, 191, 192, 193
Integral Cancer Therapy, 138, 157
Interleukin-2, 12
International Association of Cancer Victors and Friends, 169, 170
International Classification of Diseases, 194
International perspectives, 7-8, 114, 116, 169, 170
Immuno-Augmentative Therapy, 131, 136, 137
see also Foreign countries; specific countries an. regions
International Union Against Cancer, 116
Intravenous administration
Antineoplastons, 14
biologically guided chemotherapy, 118
Immuno-Augmentative Therapy, 131, 134
oxygen, 15, 47, 114
Iscador, 12, 14, 81-82, 83-86, 86
Ivy, Andrew, 207, 209

3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
J
John Birch Society, 102 Johnson, Alva, 111
Joint Commission on Accreditation of Health Care Organizations, 187
Journal of the American Medical Association, 5, 11, 44, 75, 77, 115, 119-120, 167, 168
Journal of the American Quack Association, 171
K
Kampen, Frederick van, 116
Kelley regimen, 13, 20-21, 42, 51-58
case histories, 55-58
Krebs, Ernst Jr., 102
Krebs, Ernst Sr., 102
Kunst, Leonard, 116
Kurume University, 95
Kushi, Michio, 58-66 (passim)<
L
Labeling, 112, 173, 208
Ladas, Harold, 116
Laetrile, 6, 14,18,21-22,47,99,102-107, 155, 162,192, 201-202, 212
adverse effects, 103, 107, 201
case histories, 104-106
clinical trials, 21-22, 104-105, 106-107
evaluation, 21-22, 103-107, 201-202, 232
Food and Drug Administration, 21, 22, 192, 201-202
National Cancer Institute, 21-22, 103, 105-107, 232
preclinical testing, 103-104
remission, 104, 105
State actions, 102, 201, 202
LAK cells, 12
Lancet, 98
Langer, William, 81
Laws, specific Federal, 199-212
Comprehensive Crime Control Act, 206
conspiracy, 209
Constitutional, 171, 193, 199-200
Criminal Fines Enforcement Act, 206
Employee Retirement Income Security Act, 193
False Representation Statute, 208
Federal Trade Commission Act, 207-208
Food and Drugs Act of 1906, 6
Food, Drug, and Cosmetic Act, 5-6, 7, 112, 131, 167, 199-200, 201-202, 203-207, 210, 211, 219
Mail Fraud Statute, 209
Racketeer Influenced and Corrupt Organizations Act,
194, 210 Social Security Act, 186-187, 221
v. State law, 6
see also Regulations
Leap of Faith, 155
Lechner, Peter, 49
Legal issues, 3, 5-7, 12, 16, 26, 171, 199-212, 215-223, 226
advocacy, 155, 161, 165, 169-174, 199
contracts, insurance, 186, 187-188, 189, 191, 192, 193-195
fines, 206, 207, 209, 211, 221
"freedom of choice", 7, 199, 200-203, 209
malpractice, 202, 215, 218, 222, 223
parents, 18
privacy, 6, 7, 200, 201
State v. Federal law, 6
see also Consumer protection; Crimes and criminals; Fraud; Laws, specific Federal; Licenses and permits; Litigation
Leukemia, 18, 69, 70, 73, 74, 78, 84, 95, 134-135, 202, 226, 227
LeShan's Psychotherapy, 13, 33-34
Licenses and permits, 6, 16,211-212, 215, 216-217,221, 222
insurance coverage and, 187-188, 189
unlicensed practitioners, 16, 26, 187, 215, 217, 222
see also Disciplinary measures, practitioners
Licorice, 78
Lichello, Robert, 48
Litigation, 6, 12, 16, 164, 173-174, 200, 206-207, 208, 209, 210, 211, 216-217, 222-223
biologically guided chemotherapy, 115
dietary treatments, 192
"freedom of choice", 7, 199, 200-203, 209
Hoxsey treatment, 75, 80, 81
insurance coverage, 186, 191-194, 195
privacy, 6, 7, 200, 201
see also specific case names
Liver and liver cancer, 56, 79
Gerson treatment, 46, 47
hepatitis, 136-137, 139
Pau D'Arco, 87
vitamin C, 123
Livingston, Virginia, 14, 41, 107-111, 183, 211-212
Livingston-Wheeler regimen, 14,41, 107-111, 183, 211-212
Lou Harris Associates, 154, 155, 157, 163
Lung cancer, 36, 70, 86, 87, 96, 99, 101-102, 106, 119, 123, 143-144
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
M
MacLeans (magazine), 93
Macrobiotics, 12, 14, 4142, 58-66, 162
adverse effects, 60, 63-64
American Medical Association, 60
Mail, see Postal service
Mail Fraud Statute, 209
Maisin, Joseph, 116-117
Malpractice, 202, 215, 218, 222, 223
see also Disciplinary measures, practitioners
Mass media, 5, 29, 157, 158
Antineoplastons, 95,
Gerson treatment, 44, 48
Immuno-Augmentative Therapy, 131, 135, 138
Kelley regimen, 52
television, 17, 95, 131, 138, 155, 157, 158
vitamin C, 120
Mayo Clinic, 21, 106, 122, 123-127, 232-233
McKee, Dwight, 116
McLaughlin v. Connecticut General, 192, 193
McNaughton, Andrew, 102
Meares, Ainslie, 34
Medical College of Georgia, 95
Medical College of Virginia, 100
Medical Necessity Program (Blue Cross/Blue Shield), 188
Medicaid, 186, 210
Medicare, 16, 19, 117, 185, 186-187, 190, 195, 210, 221-222, 223
Medicine Man, 157, 167
Meditation, 34
Medizone International 114
Melanoma, 49, 56, 71, 106, 185
Merck Manual of Diagnosis and Therapy, 51
Metastasis, 155
Antineoplastons, 96
biologically guided chemotherapy, 116, 119
Gerson treatment, 49, 50
Immuno-Augmentative Therapy, 143, 148
Iscador, 84, 86, 87
psychotherapy, 33, 36-37
vitamin C, 120, 122-123
Methodological issues clinical trials, 16, 21-22, 49, 80, 81, 125-127,137-138, 143-148, 204-205
evaluation, general, 4-5, 25, 225-235
Immuno-Augmentative Therapy, 137-138, 143-148, 230-231
OTA study, 3-4, 15-16
pharmacologic/biologic, 20
vitamin C evaluation, 22, 125-127
see also Statistical analysis
MetPath, 138
Mexico, 11, 13, 15, 41, 43-50, 75,76, 77, 98, 99, 103, 114, 131, 147, 170, 179, 180, 181
Miller, Mildred, 99
Minerals and mined supplements
eumetabolics, 113
Livingston-Wheeler regimen, 110
macrobiotics and, 63
Mistletoe, 13, 14, 81-86, 87
Mitchell, Herschel, 133, 134
Mohs, Frederic, 77-78
Molinari, Guy, 131, 136, 137, 142
Morgenstern, Hal 36
Mortality rates, 10
Mushrooms, 70
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
N
National Academy of Sciences, 208
National Association of Consumer Agency Administrators, 163
National Cancer Institute, 5, 11, 25, 208, 227, 233, 234
Antineoplastons, 92
biologically guided chemotherapy, 118
database, 153, 161, 163
dimethyl sulfoxide, 99
herbal treatments, 69, 74, 78, 80-81
Immuno-Augmentative Therapy, 131, 139, 140, 141, 142, 145, 148-149, 234
information dissemination, general, 153, 161-163; see also Cancer Information Service
insurance eligibility, 186, 191
laetrile, 21-22, 103, 105-107, 232
Medicare, 187
National Center for Institutions and Alternatives, 223
National Coalition for Cancer Survivorship, 30
National Council Against Health Fraud, 164, 169
National Council on Nutritional Information, 164
National Formulary, 187
National Health Care Anti-Fraud Association, 194
National Health Federation, 100, 102, 169, 170-171
National Institutes of Health, 161
see also National Cancer Institute
National Research Council, 121
Nelson, Mildred 77, 79
New England Journal of Medicine, 10, 107
New York (magazine), 131
New York Academy of Medicine, 135
New York Academy of Sciences, 134, 135
Nieper, Hans, 14, 104, 111-113, 169, 173
Nordihydroguaiaretic acid, 70-71
Nutrition, see Diet and nutrition; Macrobiotics; specific vitamins
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ

O
Ohsawa, George, 59-60
One Answer to Cancer, 52, 54
One Man Alone: An Investigation of Nutrition, Cancer, and William Donald Kelley, 20, 55
Outcomes research, 20, 36-37
Oxygen treatments, 14-15, 46, 47, 113-114, 188, 209
P
Packaging, 200, 208
labeling, 112, 173, 208
Pain and pain control, 228
Chinese medicine, 69
Gerson treatment, 49, 50
hypnosis, 36-37
vitamin C, 121, 122-123, 127
Pan American Health Organization, 131, 136, 137
Pancreatic cancer, 123
Patents
biologically guided chemotherapy, 118
Immuno-Augmentative Therapy, 137-140
Patients
associations, 169, 170, 173-174
attitudes, 3, 24-25, 29-31, 49, 50, 140, 147, 154-155, 192-193
characteristics, 3, 18, 24-25, 29, 153-154
decision making, 10, 30, 154-155, 157-158
educational attainment, 154
information sources, 17, 19, 153, 155-157, 178
legal status, 6, 7, 200, 201
see also Financial arrangements; Insurance; Pain and pain control; Quality of life
Pau D'Arco, 14, 86-87
Pauling, Linus, 14, 21, 120-127 (passim)
Penthouse, 131
People Against Cancer, 172
Peritoneal mesothelioma, 141, 143, 146, 149
Personality factors, see Attitudes
Pharmacologic and biologic approaches, 14-15, 91-127
Antineoplastons, 14, 91-97, 157, 162, 182, 183, 194, 206-207, 210, 219, 323
biologically guided chemotherapy (Revici), 14, 115-120, 169, 173-174, 202, 203, 220-221
conventional, 9-10
costs, 179-180, 181, 184
dimethyl sulfoxide, 14, 99-100, 222
evaluation of, general, 5, 228-229
FDA approval, 19
hydrazine sulfate, 15, 21, 100-102, 163
Immuno-Augmentative Therapy, 4, 8, 15, 19, 22, 131-149, 153, 162, 168, 173, 182, 183, 192, 211, 230-231, 234-235
laetrile, 6, 14, 18, 21-22, 47, 99, 102-107, 155, 162, 192, 201-202, 212
Livingston-Wheeler regimen, 14,41, 107-111, 183, 211-212
Medicare coverage, 186-187
Nieper, Hans, 14, 104, 111-115, 169, 173
Revici, Emanual, 14, 115-120, 169, 173-174, 202, 203, 220-221
see also Chemotherapy; Immunological system; Food and Drug Administration: specific vitamins
Pharmacopeial Dispensing Information, 186
pH conditions and measurements, 117, 119
Physicians
legal status, 6, 7, 187
Philippines, 13
Photodynamic therapy, 9
Podophyllotoxin, 69
Pokeroot, 78, 79
Postal Service, 7, 167, 207, 208-209
Hoxsey treatment, 75
hydrogen peroxide infusions, 114
Immuno-Augmentative Therapy, 131
Practitioners, general, 16, 199, 215-223
disciplinary measures, practitioners, 7, 54, 192, 212, 215, 217-222; see also Malpractice
unlicensed, 16, 26, 187, 215, 217 s
see also Licenses and permits; Malpractice; specific practitioners
Preclinical testing, 227-228, 234
Antineoplastons, 95 biologically guided chemotherapy, 118
Essiac, 73, 74-75
Immuno-Augmentative Therapy, 133-136, 137, 139
laetrile, 103-104
ozone infusion, 114
vitamin C, 121
see also Animal research
Prickly ash, 78
Privacy, 6, 7, 200, 201
Private sector
advocacy, 169-174
health food stores, 16, 17, 156-157
information dissemination, general, 164-174
insurance, 189-190, 191-195
Privitera, James, 201, 211
Project Cure, 171-172
Prostate cancer, 57, 93, 96, 143
Psychic surgery, 13
Psychological and behavioral approaches, 13, 14, 29-37
American Cancer Society, 30
costs of, 180, 184
evaluation, 14, 10, 20, 36-37, 229
hypnosis, 33, 36-37
imagery and visualization, 13, 33, 35-36
LeShan's psychotherapy, 33-34
macrobiotics and, 58-59, 60-61
meditation, 34 psychology, 31-33
psychosocial support, 13, 29-31, 36
see also Attitudes; Spiritual approaches
Public Health Service, 81
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
Q
Quackery, see Fraud Quackery Action Council, 164
Quality of life, 10, 30, 226, 228
dietary approaches, 43, 49, 50
Immuno-Augmentative Therapy, 144, 149
insurance eligibility and, 177, 185-186, 192
vitamin C, 121, 122
see also Pain and pain control
R
Racketeer Influenced and Corrupt Organizations Act, 194, 210
Radiation, cancer etiology, 113
Radiotherapy, 8, 9, 11, 79, 96
R.A. v. Prudential, 192, 193
Recalled by Life, 60
Rectal cancer, 11, 84, 106, 123, 125, 143,148
Red clover, 78
Regulations, 6-7, 199-212
see also Food and Drug Administration; Federal Trade
Commission; Standards
Religion, see Spiritual approaches
Remission, 228
Antineoplastons, 94-95, 96-97
biologically guided chemotherapy, 116-117, 118, 119, 120
clinical trials, 23
Immuno-Augmentative Therapy, 134, 135, 140
information on, 16, 26
laetrile, 104, 105
vitamin C, 121, 122
Research
Center for Alternative Cancer Research, 172
experimental treatments within conventional channels, 12
Federal role, 5, 24-25
historical perspective, 10
outcomes, 20
patient characteristics, 24-25
see also Animal research; Clinical trials; Evaluation; Preclinical testing
Research in Physiopathology as a Basis of Guided Chemotherapy with Special Application to Cancer, 115
Resperin Corp, 73, 74, 75
Revici, Emanual, 14, 115-120, 169, 173-174, 202, 203, 220-221
American Cancer Society, 115, 118
Revolution in Technology, Medicine and Society, 112
Rhubarb, 73
Risner v. Blue Cross/Blue Shield of Michigan, 193
Roe v. Wade, 201
Rohe, Fred, 52-53
Rosy periwinkle, 69
Rotmann, Douglas, 121
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
S
Safety, 3, 226, 233-234
Federal role, 6, 7, 199, 203, 205; see also Food and Drug Administration
Immuno-Augmentative Therapy, 138-140, 143, 145, 147, 149, 233-235
insurance eligibility and, 177-178, 185
see also Adverse effects; Toxicity
Sarcomas, 78, 84
Schneider v. Revici, 202, 203, 223
Science, 114, 134
Selenium, 116, 118-119
Shumake v. Travelers, 192
Side effects, see Adverse effects
Siegel, Bernie, 31, 36
Simonton-Atchley, Stephanie M., 13, 35-36
Simonton, O. Carl 13, 35-36
60 Minutes, 131, 138
Slippery elm, 73
Sloan-Kettering Cancer Center, 73-74, 100, 104
Smith, Elaine 10
Social Security Act, 186-187, 221
Social support, 13, 29-31, 36
Sodium, dietary, 43, 46, 113
Sorrel, 73
Speckhart, Vincent, 111
Spiegel, David, 36-37
Spiritual approaches, 12-13, 53-54, 216
Anthroposophy, 14, 81, 82-84, 85
Eastern, 58-59, 60-61
meditation, 34
Standards, 15
clinical trials, 16, 49, 80, 81, 106, 147-149, 204-205, 232, 235
eligibility, insurance, 185-195
evidence, 5, 193
pharmaceuticals, 112, 199
practitioner, 16; see Licenses and permits
safety, 7, 15
Stanford University, 21
State-level action, 199, 201, 202, 210-212, 215, 217, 218-221, 222-223
criminal practices, 26
Federal Government, relations with, 6, 210, 211-212
Gerson treatment, 43, 215
Kelley regimen, 54
Immuno-Augmentative Therapy, 131, 136, 140, 211
lnsurance coverage, 188-189, 191, 192, 193
laetrile, 102, 201, 202
see also Disciplinary measures, practitioners; Licenses
and permits; Litigation
Statistical analysis, 21
hydrazine sulfite, 101
macrobiotics, 64-05
methodological issues, 125, 126, 141, 148
mortality and survival, 10-11, 123, 124, 140-141, 149, 230-231
Steiner, Rudolph, 12, 82-83
Stillingia, 79
Stock, Chester, 104
Stomach cancer, 70, 123, 185
Strelkauskas, Anthony, 111
Sugiura, Kanematsu, 104
Support groups, 30
Surgery, 8, 9, 11
breast cancer, 11
evaluation of, 5
psychic, 13
Switzerland, 81
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ
 
T
Technical assistance 24
Technology Evaluation and Coverage Program, 188, 189
Telephone services, 30, 153, 158
American Cancer Society, 166
American Medical Association, 168
Cancer Control Society, 170
Cancer Information Service, 25, 112, 153, 161-163
Terminology
definitional issues, 11-15
unconventional, alternatives, 4
Third Opinion, 7, 178, 181
Third-party payer, see Insurance; Medicare
Thomas, Elmer, 81
Toxicity
Antineoplastons, 93
dimethyl sulfoxide, 99-100
herbal treatments, 69, 87
Immuno-Augmentative Therapy, 139, 140, 234-235
laetrile, 103, 107
Livingston-Wheeler regimen, 110
selenium, 118, 119
vitamin C, 122
Travel expenses, 178

3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ

U
University of British Columbia, 80
University of California, 21
University of Pennsylvania, 153
Unproven Methods List (ACS), 5, 15, 44, 60, 100, 112, 115, 164-166, 168, 191
Urine and urology
biologically guided chemotherapy, 117, 119
vitamin C, 122, 123, 126
U.S. Homeopathic Pharmacopoeia, 187
U.S. Pharmacopoeia, 187
U.S. v. Durovic, 209
U.S. v. Richardson, 209
U.S. v. Rutherford, 201, 206
Uterine cancer, 123, 185, 219
V
Vaccines, 14
Bacillus Calmette-Guerin, 168
Lincoln bacteriophage, 47
Livingston-Wheeler regimen, 14, 41, 107-111, 183, 211-212
Visualization and imagery, see Imagery and visualization
Vitamin A, 43, 44, 63, 104, 110
Vitamin B12, 44, 63, 64, 110, 187
Vitamin C, 14, 21, 22, 43, 63, 99, 100, 120-127, 162, 232-233
adverse effects, 121, 122, 123, 126
clinical trials, 21, 122-125, 126
evaluation, 21, 22, 122-127, 232-23
metastasis, 120, 122-123 quality of life, 121, 122
remission, 121, 122
Vitamin D, 64
Vitamins, 43, 44, 46, 52, 55, 155
litigation, 192
macrobiotics and, 63

W
Walde, David, 95-96
Warburg, Otto, 114
War on Cancer, 10
Washington Post, 100
Washington State, 136-137
Wehmeyer v. Prudential, 193
Weleda, 81
Wellness Community, 30-31
West Germany, 8, 14, 15, 81, 111-113, 131, 147
Wheatgrass regimen, 41, 42
Wigmore, Ann, 41
Wilk, Chester, 5
Women
psychosocial therapy, 31, 33, 36
see also Breast cancer
Y
Yeast, 83
You Don't Have to Die, 75, 75-76
Z
Zen Macrobiotics, 59
Zuckerberg v. Blue Cross and Blue Shield, 192
 
3-26 69-87 151-156 197-210  239-243 Top GH I  OP QR
29-37  91-126 159-172  213-221 244-245  A B C JKL S T UV
 41-66   129-147 175-193 225-235 245-249   D E F M N WYZ

OTA Report Contents

This page was posted on August 3, 1998.

Links to Recommended Vendors